Calcium homeostasis and ER stress in control of autophagy in cancer cells

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Kania, Elzbieta ^a   Pająk, Beata ^a,b   Orzechowski, Arkadiusz ^a,b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ACTIVATING TRANSCRIPTION FACTOR 6; ANTINEOPLASTIC AGENT; AUTOPHAGY PROTEIN; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; CALCIUM ION; GLUCOSE REGULATED PROTEIN 78; GLUCOSE TRANSPORTER; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INITIATION FACTOR 2ALPHA; INOSITOL TRISPHOSPHATE; INOSITOL TRISPHOSPHATE RECEPTOR; IRE 1 PROTEIN; PERK PROTEIN; PROTEIN; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; CALCIUM;

APOPTOSIS; AUTOPHAGY; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CANCER CELL; CANCER RESISTANCE; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; DISULFIDE BOND; ENDOPLASMIC RETICULUM STRESS; GENE MUTATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR MICROENVIRONMENT; UNFOLDED PROTEIN RESPONSE; ANIMAL; ENDOPLASMIC RETICULUM; HOMEOSTASIS; METABOLISM; NEOPLASM; OXIDATIVE STRESS; PATHOLOGY;

ANIMALS; AUTOPHAGY; CALCIUM; CALCIUM SIGNALING; ENDOPLASMIC RETICULUM; HOMEOSTASIS; HUMANS; NEOPLASMS; OXIDATIVE STRESS;

EID: 84925324913     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/352794     Document Type: Review

References (102)

1. D. Gozuacik and A. Kimchi, "Autophagy as a cell death and tumor suppressor mechanism, " Oncogene, vol. 23, no. 16, pp. 2891-2906, 2004.
2. S.-Y. Wang, Q.-J. Yu, R.-D. Zhang, and B. Liu, "Core signaling pathways of survival/death in autophagy-related cancer networks, " International Journal of Biochemistry and Cell Biology, vol. 43, no. 9, pp. 1263-1266, 2011.
3. R. A. Nixon, "The role of autophagy in neurodegenerative disease, " Nature Medicine, vol. 19, no. 8, pp. 983-997, 2013.
4. J. M. Vicencio, C. Ortiz, A. Criollo et al., "The inositol 1, 4, 5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1, " Cell Death and Differentiation, vol. 16, no. 7, pp. 1006-1017, 2009.
5. T. Hara, A. Takamura, C. Kishi et al., "FIP200, a ULKinteracting protein, is required for autophagosome formation in mammalian cells, "The Journal of Cell Biology, vol. 181, no. 3, pp. 497-510, 2008.
6. M. Her-Hansen, L. Bastholm, P. Szyniarowski et al., "Control of macroautophagy by calcium, calmodulin-dependent kinase Kinase-, and Bcl-2, "Molecular Cell, vol. 25, no. 2, pp. 193-205, 2007.
7. M. Filimonenko, P. Isakson, K. D. Finley et al., "The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy, "Molecular Cell, vol. 38, no. 2, pp. 265-279, 2010.
8. R. L. Macintosh and K. M. Ryan, "Autophagy in tumour cell death, " Seminars in Cancer Biology, vol. 23, no. 5, pp. 344-351, 2013.
9. F. Lozy and V. Karantza, "Autophagy and cancer cell metabolism, " Seminars in Cell and Developmental Biology, vol. 23, no. 4, pp. 395-401, 2012.
10. J. Y. Guo, B. Xia, and E. White, "Autophagy-mediated tumor promotion, " Cell, vol. 155, no. 6, pp. 1216-1219, 2013.
11. L. Galluzzi, E. Morselli, O. Kepp, M. C. Maiuri, and G. Kroemer, "Defective autophagy control by the p53 rheostat in cancer, " Cell Cycle, vol. 9, no. 2, pp. 250-255, 2010.
12. E. Morselli, L. Galluzzi, O. Kepp et al., "Anti-and pro-tumor functions of autophagy, " Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1793, no. 9, pp. 1524-1532, 2009.
13. S. W. Ryter, K. Mizumura, and A. M. K. Choi, "The impact of autophagy on cell deathmodalities, " International Journal ofCell Biology, vol. 2014, Article ID 502676, 12 pages, 2014.
14. D. Crighton, S. Wilkinson, J. O'Prey et al., "DRAM, a p53-induced modulator of autophagy, is critical for apoptosis, " Cell, vol. 126, no. 1, pp. 121-134, 2006.
15. Y. Al Dhaheri, S. Attoub, G. Ramadan et al., "Carnosol induces ROS-mediated beclin1-independent autophagy and apoptosis in triple negative breast cancer, " PLoS ONE, vol. 9, no. 10, Article ID e109630, 2014.
16. K. Larocque, P. Ovadje, S. Djurdjevic, M. Mehdi, J. Green, and S. Pandey, "Novel analogue of colchicine induces selective prodeath autophagy and necrosis in human cancer cells, " PLoS ONE, vol. 9, no. 1, Article ID e87064, 2014.
17. S. Jin, R. S. DiPaola, R. Mathew, and E. White, "Metabolic catastrophe as a means to cancer cell death, " Journal of Cell Science, vol. 120, no. 3, pp. 379-383, 2007.
18. H. Y. Xiong, X. L. Guo, X. X. Bu et al., "Autophagic cell death induced by 5-FU in Bax orPUMAdeficient human colon cancer cell, " Cancer Letters, vol. 288, no. 1, pp. 68-74, 2010.
19. D. Vara, M. Salazar, N. Olea-Herrero, M. Guzman, G. Velasco, and I. Diaz-Laviada, "Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy, " Cell Death and Differentiation, vol. 18, no. 7, pp. 1099-1111, 2011.
20. D. R. Green, L. Galluzzi, and G. Kroemer, "Metabolic control of cell death, " Science, vol. 345, no. 6203, Article ID1250256, 2014.
21. X.-X. Bao, B.-S. Xie, Q. Li, X.-P. Li, L.-H. Wei, and J.-L. Wang, "Nifedipine induced autophagy through beclin1 and mTOR pathway in endometrial carcinoma cells, " Chinese Medical Journal, vol. 125, no. 17, pp. 3120-3126, 2012.
22. D. Liu, Y. Yang, Q. Liu, and J. Wang, "Inhibitionof autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells, " Medical Oncology, vol. 28, no. 1, pp. 105-111, 2011.
23. E. J. Park, K.-J. Min, T.-J. Lee, Y. H. Yoo, Y.-S. Kim, and T. K. Kwon, "-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells, " Cell Death and Disease, vol. 5, no. 5, Article ID e1231, 2014.
24. X. Peng, W. Li, L. Yuan, R. G. Mehta, L. Kopelovich, and D. L. McCormick, "Inhibition of proliferation and induction of autophagy by atorvastatin in PC3 prostate cancer cells correlate with downregulation of Bcl2 and upregulation of miR-182 and p21, " PLoS ONE, vol. 8, no. 8, Article ID e70442, 2013.
25. M. Her-Hansen and M. Jaattela, "Connecting endoplasmic reticulumstress to autophagy by unfolded protein response and calcium, " Cell Death and Differentiation, vol. 14, no. 9, pp. 1576-1582, 2007.
26. T. Ikenoue, S. Hong, and K. Inoki, "Chapter 11 monitoring mammalian target of rapamycin (mTOR) activity, " in Methods in Enzymology, vol. 452, pp. 165-180, 2009.
27. P. Wu and Y. Z. Hu, "PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress, " Current Medicinal Chemistry, vol. 17, no. 35, pp. 4326-4341, 2010.
28. X. Sui, R. Chen, Z. Wang et al., "Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment, " Cell Death and Disease, vol. 4, no. 10, article e838, 2013.
29. K. Abdelmohsen, S. Srikantan, K. Tominaga et al., "Growth inhibition by miR-519 via multiple p21-inducing pathways, " Molecular and Cellular Biology, vol. 32, no. 13, pp. 2530-2548, 2012.
30. C. Tagliarino, J. J. Pink, K. E. Reinicke, S. M. Simmers, S. M. Wuerzberger-Davis, and D. A. Boothman, "-calpain activation in-lapachone-mediated apoptosis, " Cancer Biology and Therapy, vol. 2, no. 2, pp. 141-152, 2003.
31. B. Pajak and A. Orzechowski, "Ethylenediaminetetraacetic acid affects subcellular expression of clusterin protein in human colon adenocarcinoma COLO205 cell line, " Anti-Cancer Drugs, vol. 18, no. 1, pp. 55-63, 2007.
32. J.-P. Decuypere, D. Kindt, T. Luyten et al., "mTOR-controlled autophagy requires intracellular Ca2+ signaling, " PLoS ONE, vol. 8, no. 4, Article ID e61020, 2013.
33. S. Sarkar, R. A. Floto, Z. Berger et al., "Lithium induces autophagy by inhibiting inositol monophosphatase, " The Journal of Cell Biology, vol. 170, no. 7, pp. 1101-1111, 2005.
34. R. Chen, X. Zeng, R. Zhang et al., "Cav1. 3 channel 1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers, " Urologic Oncology: Seminars and Original Investigations, vol. 32, no. 5, pp. 524-536, 2014.
35. H.-K. Rim, S. Cho, D.-H. Shin et al., "T-type Ca2+ channel blocker, KYS05090 induces autophagy and apoptosis in A549 cells through inhibiting glucose uptake, " Molecules, vol. 19, pp. 9864-9875, 2014.
36. G. Santoni, M. Santoni, and M. Nabissi, "Functional role of T-type calcium channels in tumour growth and progression: prospective in cancer therapy, " British Journal of Pharmacology, vol. 166, no. 4, pp. 1244-1246, 2012.
37. B. Pajak, E. Kania, B. Gajkowska, and A. Orzechowski, "Verapamil-induced autophagy-like process in colon adenocarcinoma COLO205 cells; the ultrastructural studies, " Pharmacological Reports, vol. 64, no. 4, pp. 991-996, 2012.
38. Y. Zhang, J. Zhang, D. Jiang et al., "Inhibition of T-type Ca2+ channels by endostatin attenuates human glioblastoma cell proliferation and migration, " British Journal of Pharmacology, vol. 166, no. 4, pp. 1247-1260, 2012.
39. W. Qiu, M. Su, F. Xie et al., "Tetrandrine blocks autophagic flux and induces apoptosis via energetic impairment in cancer cells, " Cell Death and Disease, vol. 5, no. 3, Article ID e1123, 2014.
40. T. D. Ardizzone, X.-H. Lu, and D. S. Dwyer, "Calcium-independent inhibition of glucose transport in PC-12 and L6 cells by calciumchannel antagonists, " American Journal of Physiology-Cell Physiology, vol. 283, no. 2, pp. C579-C586, 2002.
41. F. Pingsheng, Z. Tengyue, H. Qiang, W. Qiang, S. Xin, and Q. Liting, "Basic and clinical research on the therapeutic effect of intervention in primary liver cancer by targeted intra-arterial verapamil infusion, " Cell Biochemistry and Biophysics, vol. 62, no. 1, pp. 59-67, 2012.
42. D. Trompier, X.-B. Chang, R. Barattin, A. Du Moulinet D'Hardemare, A. Di Pietro, and H. Baubichon-Cortay, "Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1, " Cancer Research, vol. 64, no. 14, pp. 4950-4956, 2004.
43. A. Colucci, R. Giunti, S. Senesi, F. L. Bygrave, A. Benedetti, and A. Gamberucci, "Effect of nifedipine on capacitive calcium entry in Jurkat T lymphocytes, " Archives of Biochemistry and Biophysics, vol. 481, no. 1, pp. 80-85, 2009.
44. W. Jia, H. H. Pua, Q.-J. Li, and Y.-W. He, "Autophagy regulates endoplasmic reticulum homeostasis and calcium mobilization in T lymphocytes, " The Journal of Immunology, vol. 186, no. 3, pp. 1564-1574, 2011.
45. H. Liu, J. D. Hughes, S. Rollins, B. Chen, and E. Perkins, "Calcium entry via ORAI1 regulates glioblastoma cell proliferation and apoptosis, " Experimental and Molecular Pathology, vol. 91, no. 3, pp. 753-760, 2011.
46. H. Wu, Z. Ding, D. Hu et al., "Central role of lactic acidosis in cancer cell resistance to glucose deprivation-induced cell death, " Journal of Pathology, vol. 227, no. 2, pp. 189-199, 2012.
47. A. Strigun, F. Noor, A. Pironti, J. Niklas, T. H. Yang, and E. Heinzle, "Metabolic flux analysis gives an insight on verapamil induced changes in central metabolism of HL-1 cells, " Journal of Biotechnology, vol. 155, no. 3, pp. 299-307, 2011.
48. I. Dando, M. Donadelli, C. Costanzo et al., "Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells, " Cell Death and Disease, vol. 4, no. 6, article e664, 2013.
49. R. S. DiPaola, D. Dvorzhinski, A. Thalasila et al., "Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy, " Prostate, vol. 68, no. 16, pp. 1743-1752, 2008.
50. P. K. Kandala and S. K. Srivastava, "Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling Glucose regulatory protein 78 and AMPK, " Oncotarget, vol. 3, no. 4, pp. 435-449, 2012.
51. M. L. Macheda, S. Rogers, and J. D. Best, "Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer, " Journal of Cellular Physiology, vol. 202, no. 3, pp. 654-662, 2005.
52. A. Krzeslak, K. Wojcik-Krowiranda, E. Forma et al., "Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers, " Pathology and Oncology Research, vol. 18, no. 3, pp. 721-728, 2012.
53. G. F. Guo, Y. C. Cai, B. Zhang et al., "Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosis, " Medical Oncology, vol. 28, no. 1, pp. 197-203, 2011.
54. S. Freier, O. Weiss, M. Eran et al., "Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon, " Gut, vol. 44, no. 5, pp. 704-708, 1999.
55. J. C.-H. Li and R. Li, "RAV12 accelerates the desensitization of Akt/PKB pathway of insulin-like growth factor I receptor signaling in COLO205, " Cancer Research, vol. 67, no. 18, pp. 8856-8864, 2007.
56. S. Baghdiguian, B. Verrier, C. Gerarda, and J. Fantini, "Insulin like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth, " Cancer Letters, vol. 62, no. 1, pp. 23-33, 1992.
57. R. S. MacDonald, W. H. Thornton Jr., and T. L. Bean, "Insulin and IGF-1 receptors in a human intestinal adenocarcinoma cell line (Caco-2): regulation of Na+ glucose transport across the brush border, " Journal of Receptor Research, vol. 13, no. 7, pp. 1093-1113, 1993.
58. M. Shanmugam, S. K. McBrayer, J. Qian et al., "Targeting glucose consumption and autophagy inmyeloma with the novel nucleoside analogue 8-aminoadenosine, " Journal of Biological Chemistry, vol. 284, no. 39, pp. 26816-26830, 2009.
59. T.-K. Ha and S.-G. Chi, "CAV1/caveolin 1 enhances aerobic glycolysis in colon cancer cells via activation of SLC2A3/GLUT3 transcription, " Autophagy, vol. 8, no. 11, pp. 1684-1685, 2012.
60. T.-K. Ha, N.-G. Her, M.-G. Lee et al., "Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulatingHMGA1-mediated GLUT3 transcription, " Cancer Research, vol. 72, no. 16, pp. 4097-4109, 2012.
61. A. Garufi, A. Ricci, D. Trisciuoglio et al., "Glucose restriction induces cell death in parental but not in homeodomaininteracting protein kinase 2-depleted RKO colon cancer cells: molecular mechanisms and implications for tumor therapy, " Cell Death and Disease, vol. 4, article e639, 2013.
62. X. Wang, C. O. Eno, B. J. Altman et al., "ER stress modulates cellular metabolism, " Biochemical Journal, vol. 435, no. 1, pp. 285-296, 2011.
63. S. Meister, B. Frey, V. R. Lang et al., "Calcium channel blocker verapamil enhances endoplasmic reticulumstress and cell death induced by proteasome inhibition inmyeloma cells, " Neoplasia, vol. 12, no. 7, pp. 550-561, 2010.
64. A. Avivar-Valderas, E. Salas, E. Bobrovnikova-Marjon et al., "PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment, " Molecular and Cellular Biology, vol. 31, no. 17, pp. 3616-3629, 2011.
65. M. Ogata, S.-I. Hino, A. Saito et al., "Autophagy is activated for cell survival after endoplasmic reticulum stress, "Molecular and Cellular Biology, vol. 26, no. 24, pp. 9220-9231, 2006.
66. E. Zalckvar, H. Berissi, L. Mizrachy et al., "DAP-kinasemediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy, " EMBO Reports, vol. 10, no. 3, pp. 285-292, 2009.
67. X. Cheng, H. Liu, C. C. Jiang et al., "Connecting endoplasmic reticulum stress to autophagy through IRE1/JNK/beclin-1 in breast cancer cells, " International Journal ofMolecularMedicine, vol. 34, no. 3, pp. 772-781, 2014.
68. M. Salazar, A. Carracedo, I. J. Salanueva et al., "Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells, " Journal of Clinical Investigation, vol. 119, no. 5, pp. 1359-1372, 2009.
69. J. A. Williams, Y. Hou, H.-M. Ni, and W.-X. Ding, "Role of intracellular calcium in proteasome inhibitor-induced endoplasmic reticulum stress, Autophagy, and cell death, " Pharmaceutical Research, vol. 30, no. 9, pp. 2279-2289, 2013.
70. P. Agostinis and A. Samali, Endoplasmic Reticulum Stress in Health and Disease, Springer, 2012.
71. H. Xi, M. Kurtoglu, H. Liu et al., "2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion, " Cancer Chemotherapy and Pharmacology, vol. 67, no. 4, pp. 899-910, 2011.
72. E. Ogier-Denis, C. Bauvy, F. Cluzeaud, A. Vandewalle, and P. Codogno, "Glucose persistence on high-mannose oligosaccharides selectively inhibits the macroautophagic sequestration of N-linked glycoproteins, " Biochemical Journal, vol. 345, no. 3, pp. 459-466, 2000.
73. B. Luo and A. S. Lee, "The critical roles of endoplasmic reticulumchaperones and unfolded protein response in tumorigenesis and anticancer therapies, " Oncogene, vol. 32, no. 7, pp. 805-818, 2013.
74. J. Li, M. Ni, B. Lee, E. Barron, D. R. Hinton, and A. S. Lee, "The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells, " Cell Death and Differentiation, vol. 15, no. 9, pp. 1460-1471, 2008.
75. R. Zhang, Y. Chung, H. S. Kim, D. H. Kim, W. Y. Chang, and J. W. Hyun, "20-O-(-D-glucopyranosyl)-20(S)-protopanaxadiol induces apoptosis via induction of endoplasmic reticulumstress in human colon cancer cells, " Oncology Reports, vol. 29, no. 4, pp. 1365-1370, 2013.
76. S.-M. Huang, C.-W. Cheung, C.-S. Chang et al., "Phloroglucinol derivativeMCPP induces cell apoptosis in human colon cancer, " Journal ofCellular Biochemistry, vol. 112, no. 2, pp. 643-652, 2011.
77. X. Xing, Y. Li, H. Liu, L. Wang, and L. Sun, "Glucose regulated protein 78 (GRP78) is overexpressed in colorectal carcinoma and regulates colorectal carcinoma cell growth and apoptosis, " Acta Histochemica, vol. 113, no. 8, pp. 777-782, 2011.
78. H. H. Kitzman Jr., R. J. McMahon, A. M. Aslanian, P. M. Fadia, and S. C. Frost, "Differential regulation of GRP78 and GLUT1 expression in 3T3-L1 adipocytes, " Molecular and Cellular Biochemistry, vol. 162, no. 1, pp. 51-58, 1996.
79. Y. Wang, W. Wang, S. Wang, J. Wang, S. Shao, and Q. Wang, "Down-regulation of GRP78 is associated with the sensitivity of chemotherapy to VP-16 in small cell lung cancer NCI-H446 cells, " BMC Cancer, vol. 8, article 372, 2008.
80. D. P. K. Wong, J. M. T. Chu, V. K. L. Hung et al., "Modulation of endoplasmic reticulum chaperone GRP78 by high glucose in hippocampus of streptozotocin-induced diabetic mice and C6 astrocytic cells, " Neurochemistry International, vol. 63, no. 6, pp. 551-560, 2013.
81. H. L. Bennett, J. T. Fleming, J. O'Prey, K. M. Ryan, and H. Y. Leung, "Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucoseregulated protein 78/BiP in prostate cancer cells, " Cell Death and Disease, vol. 1, no. 9, article e72, 2010.
82. L. Song, H. Liu, L. Ma, X. Zhang, Z. Jiang, and C. Jiang, "Inhibition of autophagy by 3-MA enhances endoplasmic reticulum stress-induced apoptosis in human nasopharyngeal carcinoma cells, " Oncology Letters, vol. 6, no. 4, pp. 1031-1038, 2013.
83. X.-H. Ma, S.-F. Piao, S. Dey et al., "Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance inmelanoma, " Journal of Clinical Investigation, vol. 124, no. 3, pp. 1406-1417, 2014.
84. K. M. A. Rouschop, T. Van Den Beucken, L. Dubois et al., "The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genesMAP1LC3B and ATG5, "The Journal of Clinical Investigation, vol. 120, no. 1, pp. 127-141, 2010.
85. M. Kumano, J. Furukawa, M. Shiota et al., "Cotargeting stressactivated Hsp27 and autophagy as a combinatorial strategy to amplify endoplasmic reticular stress in prostate cancer, " Molecular CancerTherapeutics, vol. 11, no. 8, pp. 1661-1671, 2012.
86. E. M. Stewart, J. A. Aquilina, S. B. Easterbrook-Smith et al., "Effects of glycosylation on the structure and function of the extracellular chaperone clusterin, " Biochemistry, vol. 46, no. 5, pp. 1412-1422, 2007.
87. J. O'Sullivan, L. Whyte, J. Drake, and M. Tenniswood, "Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis, " Cell Death and Differentiation, vol. 10, no. 8, pp. 914-927, 2003.
88. S.-W. Kang, S.-Y. Yoon, J.-Y. Park, and D.-H. Kim, "Unglycosylated clusterin variant accumulates in the endoplasmic reticulumand induces cytotoxicity, "The International Journal of Biochemistry and Cell Biology, vol. 45, no. 2, pp. 221-231, 2013.
89. B. Pajak and A. Orzechowski, "Regulation of clusterin activity by calcium, " Advances in Cancer Research, vol. 104, no. 1, pp. 33-58, 2009.
90. R. M. Moretti, S. Mai, M. M. Marelli, F. Rizzi, S. Bettuzzi, and P. Limonta, "Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells, " International Journal of Oncology, vol. 39, no. 1, pp. 225-234, 2011.
91. A. Sala, S. Bettuzzi, S. Pucci, O. Chayka, M. Dews, and A. Thomas-Tikhonenko, "Regulation of CLU gene expression by oncogenes and epigenetic factors: implications for tumorigenesis, " Advances in Cancer Research, vol. 105, pp. 115-132, 2009.
92. A. A. Powolny, A. Bommareddy, E.-R. Hahm et al., "Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer, " Journal of the National Cancer Institute, vol. 103, no. 7, pp. 571-584, 2011.
93. S. Pucci, E. Bonanno, F. Pichiorri, C. Angeloni, and L. G. Spagnoli, "Modulation of different clusterin isoforms in human colon tumorigenesis, " Oncogene, vol. 23, no. 13, pp. 2298-2304, 2004.
94. A. R. Wyatt, J. J. Yerbury, P. Berghofer et al., "Clusterin facilitates in vivo clearance of extracellular misfolded proteins, " Cellular and Molecular Life Sciences, vol. 68, no. 23, pp. 3919-3931, 2011.
95. E. Balantinou, I. P. Trougakos, N. Chondrogianni, L. H. Margaritis, and E. S. Gonos, "Transcriptional and posttranslational regulation of clusterin by the two main cellular proteolytic pathways, " Free Radical Biology and Medicine, vol. 46, no. 9, pp. 1267-1274, 2009.
96. B. Xu, B. Bai, S. Sha et al., "Interleukin-1 induces autophagy by affecting calcium homeostasis and trypsinogen activation in pancreatic acinar cells, " International Journal of Clinical and Experimental Pathology, vol. 7, no. 7, pp. 3620-3631, 2014.
97. D. Zhang, J. Li, F. Wang, J. Hu, S. Wang, and Y. Sun, "2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy, " Cancer Letters, vol. 355, pp. 176-183, 2014.
98. Y. Y. Zhao, Y. Tian, J. Zhang et al., "Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo, "DrugDesign, DevelopmentandTherapy, vol. 8, pp. 1827-1837, 2014.
99. G. Karsli-Uzunbas, J. Y. Guo, S. Price et al., "Autophagy is required for glucose homeostasis and lung tumormaintenance, " Cancer Discovery, vol. 4, no. 8, pp. 914-927, 2014.
100. A. Ko, A. Kanehisa, I. Martins et al., "Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling, " Cell Death and Differentiation, vol. 21, no. 1, pp. 92-99, 2014.
101. M. T. Rosenfeldt, J. O'Prey, J. P. Morton et al., "P53 status determines the role of autophagy in pancreatic tumour development, " Nature, vol. 504, no. 7479, pp. 296-300, 2013.
102. B. Gini, C. Zanca, D. Guo et al., "The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas, " Clinical Cancer Research, vol. 19, no. 20, pp. 5722-5732, 2013.